| http://www.w3.org/ns/prov#value | - The drug companies fight hard against including side effect that might limit later marketing or FDA approval, and they grossly under-report side effects even to IRB boards, even eliminating deaths reported on other clinical trials not known to the IRB board. [IRB boards are reluctant to make a difficult stand, especially in large multi-center trials, they will go along with the rest.] I have also wi
|
